Skip to content

MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.

Statistical Mapping of the Brain in Progressive Supranuclear Palsy, Essential Tremor, Parkinson Disease, Parkinsonism, and REM Behavior Disorder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01547481
Enrollment
50
Registered
2012-03-07
Start date
2011-12-31
Completion date
2015-12-31
Last updated
2018-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Movement Disorders (Incl Parkinsonism), REM Sleep Behavior Disorder, Tremor Familial Essential, 1

Brief summary

This proposal is focused on developing a reliable, valid, and reproducible imaging techniques and statistical methodology for segregation of various forms of Parkinsonism from healthy adults without Parkinsonism.

Detailed description

This proposal is focused on developing a reliable, valid, and reproducible imaging techniques and statistical methodology for segregation of various forms of Parkinsonism from healthy adults without Parkinsonism. We focus on early diagnosis of Parkinsonism, other tremor disorders, and determine how imaging might be used to improve diagnosis. The purpose of this protocol is to gather a multi-modal dataset to explore and validate the investigator's previous research findings in prior studies.

Interventions

None listed

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Control • Age 35-85 Parkinson Disease (PD) Age 35-85 Diagnosis of clinically definite PD made by a movement disorders specialist, with evidence of the following features: * Presence of bradykinesia and 1 or both of the following: 1. Rest tremor 2. Rigidity * Asymmetric Onset * Progressive motor symptoms * Levodopa responsive * Duration at least 1 but not more than 10 years * Hoehn and Yahr Stage 1-2 Progressive Supranuclear Palsy (PSP) Age 40-85 Diagnosis of clinically definite PSP, with the following features: * Gradually progressive disorder. * Onset after age 39 * Supranuclear palsy\* and postural instability with falls in the first year of disease onset\*. * No evidence of other disease. Parkinsonism of Other or Undetermined Cause (POC) Age 35-85 Diagnosis of parkinsonism of undetermined other other cause by a movement disorders specialist, with the following features: * Signs and symptoms of Parkinsonism including 1. Bradykinesia 2. Mixed or resting tremor 3. Rigidity 4. Characteristic deficits of gait and balance associated with Parkinsonism Essential Tremor (ET) Age 35-85 Diagnosis of essential tremor, with the following features: * A 2+ postural tremor of at least 1 arm (a head tremor may also be present, but is not sufficient for diagnosis) * On examination, there must be 1. a 2+ kinetic tremor during at least 4 tasks, or; 2. a 2+ kinetic tremor on 1 task and a 3+ kinetic tremor on a second task; tasks include pouring water, using a spoon to drink water, drinking water, finger-to-nose, and drawing a spiral * If on examination, the tremor is present in the dominant hand, then by report, it must interfere with at least 1 activity of daily living. REM Behavior Disorder (RBD) Age 25 - 85 Documented diagnosis of REM sleep behavior disorder (RBD) by a sleep medicine specialist, with the following clinical features: * Presence of REM sleep without atonia on polysomnography * At least one of the following conditions: 1. Sleep-related, behaviors by history (eg, dream enactment behavior) 2. Abnormal REM sleep behavior documented during PSG monitoring

Exclusion criteria

Healthy Control * Pregnancy * First-degree blood relative affected by PD * Neurodegenerative disease * History of repeated head injury, encephalitis, brain surgery, stroke, dementia, neuroleptic exposure, or serious medical illness that may interfere with participation. Parkinson Disease (PD) * Any

Design outcomes

Primary

MeasureTime frameDescription
fMRI compared between cohortsone time at initial visitStudying resting brain activity between healthy adults, participants with Parkinson's and participants with REM Behavior Disorder.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026